Acatalasia
(Redirected from Takahara's disease)
Acatalasia is a rare autosomal recessive genetic disorder characterized by the absence or very low levels of the enzyme catalase. This enzyme is crucial for the breakdown of hydrogen peroxide into water and oxygen. The deficiency of catalase leads to the accumulation of hydrogen peroxide, which can cause damage to cells and tissues.
Signs and Symptoms[edit | edit source]
Individuals with acatalasia may be asymptomatic or present with a range of symptoms. Common symptoms include:
- Oral ulcers
- Gangrene of the gums
- Increased susceptibility to infections
- Delayed wound healing
Genetics[edit | edit source]
Acatalasia is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the defective gene, one from each parent, to manifest the disorder. The gene responsible for acatalasia is the CAT gene, which provides instructions for making the enzyme catalase.
Diagnosis[edit | edit source]
Diagnosis of acatalasia is typically made through:
- Blood tests to measure catalase activity
- Genetic testing to identify mutations in the CAT gene
Treatment[edit | edit source]
There is no specific treatment for acatalasia. Management focuses on preventing and treating symptoms and complications. This may include:
- Good oral hygiene to prevent oral ulcers and infections
- Prompt treatment of infections with antibiotics
- Regular monitoring by healthcare professionals
Epidemiology[edit | edit source]
Acatalasia is an extremely rare disorder, with higher prevalence reported in certain populations, such as in Japan and Switzerland. The exact incidence and prevalence are not well-documented due to the rarity of the condition.
History[edit | edit source]
The disorder was first described in 1948 by Japanese scientist Takahara and is sometimes referred to as Takahara's disease.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD